× Industry Reports Services Press Release Contact us About us

North America Cell Line Development Market Forecast 2027 By Source (Mammalian, Non-mammalian {Insects, Amphibians}), By Product (Reagents & Media, Equipment {Incubator, Centrifuge, Bioreactor, Storage Equipment, Microscope}, Accessories & Consumables), By Cell Line (Recombinant, Hybridomas, Continuous Cell Line, Primary Cell Line), By Application (Bioproduction, Drug Discovery, Toxicity Testing, Tissue Engineering, Research), Research Report, Country Outlook (U.S., Canada), COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share
Published Date: September 2021 | Publisher: Graphical Research Report ID: GR1067 | Delivery : PDF  Request Free Sample

North America Cell Line Development Market size surpassed USD 1.4 billion in 2020 and is expected to witness 11% CAGR from 2021 to 2027. Growing demand of cell therapy in cancer treatment will boost the market expansion.

 

North America Cell Line Development Market

Get more details on this report - Request Free Sample PDF

Advancement in micro robotics, single cell dispensaries, flow cytometry had significant impact on the cell line development market revenue. Flow cytometry has gradually impacted on cell line development, as it increases the work efficiency during research work.  Cell line development is very time-consuming work, at every single stage researcher faces limitations and challenges. From last few years, researcher have been developing advanced tools and strategies to reduce the challenges, especially for complex biologics such as DTE proteins.

North America Market, By Product

Equipment segment is set to garner more than 11% growth rate through 2027. Numerous cell line development applications such as drug screening, biologics production is fueling the market demand. Centrifuge, and incubators are some of the main equipment playing important part in cell line culture. Cell line culture requires specific & strictly controlled environment. Specially designed incubators provide optimum growth conditions to cell culture such as humidity, temperature and CO2.

North America Market, By Source

Mammalian source segment held over 71% North America cell line development market share in 2020. Chinese hamster ovary cells are commonly used mammalian cell. Most of the mammalian cells such as HEK293, HT-1080, and NS0 among others are used for therapeutic and recombinant protein production in large proportion.

North America Market, By Cell Line Type

North America Cell Line Development Market, By Cell Line Type

Get more details on this report - Request Free Sample PDF

Hybridoma cell line segment will observe over 10% growth rate during the forecast period. Hybridoma technology is a technique that is used to generate monoclonal antibodies. Hybridoma cell line are used in applications such as production of monoclonal antibody, immunoglobin, and others. It is helpful in research work and development of assay. Improving focus on production of monoclonal antibodies will fuel the segment growth.

North America Market, By Application

Bioproduction application segment value was around USD 658 million in 2020. Pharmaceutical industries focus on the development of therapeutic drugs including vaccines, cell therapies, protein-based therapies. Increasing number of biosimilars and biologic products will fuel the market demand with high productivity.

North America Market, By Country

The U.S. cell line development market revenue is poised to expand at 11.4% CAGR till 2027. Rising adoption of novel technology, development of tools and techniques in research, growing demand of gene therapy in the U.S will drive the market size in the country.

Competitive Industry Landscape

Major players operating in the market are WuXi AppTec, Sartorius, Selexis, Thermo Fisher Scientific, Sigma-Aldrich (Merck), Lonza Group, GE Healthcare, Corning Inc., GVK BIO, and Vista Biologicals. Companies focusing on research and development work, also production of novel product to gain more competitive advantage in the industry.
 

Frequently Asked Question(FAQ) :

The market size for cell line development in North America was exceeded USD 1.4 billion in 2020 and will record 11% CAGR through 2027 on account of strong demand for cell therapy in cancer treatment.
The market share for cell line development in North America from the equipment segment could grow at over 11% CAGR through 2027 with rising demand for biologics production and drug screening.
Mammalian cell line development captured more than 71% share of North America market in 2020 and will grow due to the trend in therapeutic and recombinant protein production.
The industry share for cell line development in North America from the hybridoma segment could expand at more than 10% share through 2027 due to increasing research activities.
Thermo Fisher Scientific, WuXi AppTec, GE Healthcare, Vista Biologicals, Sigma-Aldrich, Sartorius, Lonza Group and Corning Inc., are some of the leading companies in North America market.

Premium Report

Have questions?
  • Inquire Before Buying
  • Why Choose us?

    • on-time delivery On-Time Delivery

      We commit to on-time delivery of reports to keep you ahead.

    • assured quality Assured Quility

      With a wide network of industry experts and trained in-house analysts, we assure best service quality.

    • Custom Research Service

      We offer research services to meet specific client requirements and provide them with actionable insights on target markets.

    • payment security Payment Security

      Our safe payment gateway gives you full control of your personal data, at all times.

    Connect with our sales team

     1-800-986-6917

     [email protected]